In the first of the articles included in this eBook, Carl June describes the development of CAR T cells as “a long and winding road.” Read the insightful interview and a series of other articles discussing the complexities of the immune system and strategies for success working with CAR T cells for therapeutic development. Horizon Discovery’s gene modulation capabilities that can help on this journey.
You'll learn about:
- The new lease of life for shRNA
- Cell-based immunotherapies for solid tumors
- Helper T cells role in cancer immunotherapy
- Primary immune cell CRISPR screening